logo-wt

HEALING THOSE WHO PROTECT US

At Operator Relief Fund (ORF), we have made it our mission to bring best-in-class wellness treatment and services to shadow warriors struggling with operator syndrome (PTS). The scars endured from service have impact on mind, body and spirit of the operators and their families. Shadow Warrior fatalities have more than doubled from 2022-2023, mainly attributed to cancer and suicide. It is our passion and duty to help them begin a journey to health and wellness.

OUR APPROACH

ORF provides funding for Advanced Stellate Ganglion Block (ASGB) treatment for shadow warriors to enable a journey to health and wellness. The procedure calms the constant fight or flight state so the operator can then begin to address other issues and focus on living a healthy lifestyle.

OUR IMPACT

0

To date, ORF has funded 347 Shadow Warrior Health & Recovery Journeys.

Based on year 1 of a 3 year study, we are seeing 65-80% efficacy of reduced PTS symptoms at 9 months and counting for both active and veteran participants.

efficacy

WHO WE SERVE

Shadow warriors are defined as members and veterans of special operations and intelligence communities, with a focus on operational and direct support personnel who have deployed in service to their special operation units and intelligence agencies.

WHAT IS ASGB

Advanced Stellate Ganglion Block (ASGB) is an injection of medication into a collection of nerves at the bottom front side of the neck. When administered into both sides of the neck, it has proven, lasting impact. It resets the sympathetic nervous system fight or flight response to its baseline.

DIAGNOSTICS

  • Hormone imbalances
  • Psychological
  • Sleep
  • Alcohol dependence
  • Nutrient deficiency
  • Thyroid, cardiac, diabetes, liver / kidney function

PARTNERS AND PROVIDERS

Age Rejuvenation
All Secure Foundation
AllTru
America's Warrior Partnership
Donovan and Bank Foundation
Tullman Family Office

OPERATORS SERVED

0

2022

0

2023

0

2024

0

2025

ORF has partnered with America's Warrior Partnership to formalize a pre and post-treatment capture of patient data over 3 years to understand the impact and efficacy of this treatment. A goal would be adoption of the administration of ASGB by the VA and active duty medical personnel, as well as, civilian insurance providers.